Neurological complications of chronic kidney disease

被引:128
作者
Krishnan, Arun V. [1 ]
Kiernan, Matthew C. [2 ]
机构
[1] Univ New S Wales, Translat Neurosci Facil, Sch Med Sci, Sydney, NSW 2052, Australia
[2] Univ New S Wales, Prince Wales Med Res Inst, Sydney, NSW 2052, Australia
基金
英国医学研究理事会;
关键词
RESTLESS LEGS SYNDROME; CHRONIC-RENAL-FAILURE; PERIPHERAL-NERVE FUNCTION; CARPAL-TUNNEL-SYNDROME; MAINTENANCE HEMODIALYSIS-PATIENTS; MIDDLE MOLECULE HYPOTHESIS; SILENT CEREBRAL INFARCTION; COGNITIVE FUNCTION; DIABETIC-NEUROPATHY; UREMIC NEUROPATHY;
D O I
10.1038/nrneurol.2009.138
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Chronic kidney disease (CKD) is a critical and rapidly growing global health problem. Neurological complications occur in almost all patients with severe CKD, potentially affecting all levels of the nervous system, from the CNS through to the PNS. Cognitive impairment, manifesting typically as a vascular dementia, develops in a considerable proportion of patients on dialysis, and improves with renal transplantation. Patients on dialysis are generally weaker, less active and have reduced exercise capacity compared with healthy individuals. Peripheral neuropathy manifests in almost all such patients, leading to weakness and disability. Better dialysis strategies and dietary modification could improve outcomes of transplantation if implemented before surgery. For patients with autonomic neuropathy, specific treatments, including sildenafil for impotence and midodrine for intradialytic hypotension, are effective and well tolerated. Exercise training programs and carnitine supplementation might be beneficial for neuromuscular complications, and restless legs syndrome in CKD responds to dopaminergic agonists and levadopa treatment. The present Review dissects the pathophysiology of neurological complications related to CKD and highlights the spectrum of therapies currently available.
引用
收藏
页码:542 / 551
页数:10
相关论文
共 141 条
[1]   MULTICENTER TRIAL OF L-CARNITINE IN MAINTENANCE HEMODIALYSIS-PATIENTS .2. CLINICAL AND BIOCHEMICAL EFFECTS [J].
AHMAD, S ;
ROBERTSON, HT ;
GOLPER, TA ;
WOLFSON, M ;
KURTIN, P ;
KATZ, LA ;
HIRSCHBERG, R ;
NICORA, R ;
ASHBROOK, DW ;
KOPPLE, JD .
KIDNEY INTERNATIONAL, 1990, 38 (05) :912-918
[2]   DIALYSIS ENCEPHALOPATHY SYNDROME - POSSIBLE ALUMINUM INTOXICATION [J].
ALFREY, AC ;
LEGENDRE, GR ;
KAEHNY, WD .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (04) :184-188
[3]   THE FUNCTION OF LARGE AND SMALL NERVE-FIBERS IN RENAL-FAILURE [J].
ANGUSLEPPAN, H ;
BURKE, D .
MUSCLE & NERVE, 1992, 15 (03) :288-294
[4]  
[Anonymous], 1997, Am J Kidney Dis, V30, pS15
[5]  
*ANZDATA, 2008, 31 ANZDATA
[6]   DIALYSIS DISEQUILIBRIUM SYNDROME - CURRENT CONCEPTS ON PATHOGENESIS AND PREVENTION [J].
ARIEFF, AI .
KIDNEY INTERNATIONAL, 1994, 45 (03) :629-635
[7]   Evaluation of effect of renal transplantation in treatment of restless legs syndrome [J].
Azar, S. A. ;
Hatefi, R. ;
Talebi, M. .
TRANSPLANTATION PROCEEDINGS, 2007, 39 (04) :1132-1133
[8]   THE MIDDLE MOLECULE HYPOTHESIS IN PERSPECTIVE [J].
BABB, AL ;
AHMAD, S ;
BERGSTROM, J ;
SCRIBNER, BH .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1981, 1 (01) :46-50
[9]   Chronic kidney disease in the developing world [J].
Barsoum, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10) :997-999
[10]   Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics [J].
Benes, Heike ;
Walters, Arthur S. ;
Allen, Richard P. ;
Hening, Wayne A. ;
Kohnen, Ralf .
MOVEMENT DISORDERS, 2007, 22 :S401-S408